Leaflet COLISTIMETAT SODIC XELLIA 1MUI 1000000UI powder for injection / infusion solution


Indicated for: bacterial infections

Route of administration: injectable / infusion

Substance: sodium colistimetate (antibacterial antibiotic)

ATC: J01XB01 (Antiinfectives for systemic use | Other antibacterials | Polymyxins)

Colistimethate sodium is an antibiotic used to treat severe bacterial infections caused by gram-negative bacteria, such as Pseudomonas aeruginosa or Acinetobacter baumannii. It is often used as a last-line treatment for infections resistant to other antibiotics.

The medication is administered intravenously or via inhalation, depending on the type and location of the infection. It is important to use it as directed by your doctor to prevent the development of bacterial resistance.

Side effects may include kidney function impairment, neurotoxicity (dizziness, tingling), or allergic reactions. In rare cases, severe complications may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as kidney diseases, to ensure the safe use of colistimethate sodium.

General data about COLISTIMETAT SODIC XELLIA 1MUI 1000000UI

  • Substance: sodium colistimetate
  • Date of last drug list: 02-10-2013
  • Commercial code: W60000001
  • Concentration: 1000000UI
  • Pharmaceutical form: powder for injection / infusion solution
  • Quantity: 10
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).